Josh Neiman
About Josh Neiman
Josh Neiman is the Chief Commercial Officer for North America and Europe at BeiGene, with extensive experience in oncology product management and marketing.
Title
Josh Neiman is the Chief Commercial Officer for North America & Europe at BeiGene. He joined the company in July 2018.
Education and Expertise
Josh Neiman achieved his MBA from Northwestern University - Kellogg School of Management, where he studied from 2004 to 2006. He also holds a B.A. in Molecular and Cell Biology from the University of California, Berkeley, completed from 1996 to 2000.
Professional Background
Josh Neiman has a robust career with significant roles in oncology product management and marketing. He gained experience at Genentech working on products like Rituxan and Herceptin. He also managed US Market Access & Reimbursement and US Marketing for Kyprolis at Onyx Pharmaceuticals. Before his current role at BeiGene, he served as Vice President of Marketing at Flatiron Health, focusing on oncology data and software solutions.
Career at BeiGene
Since joining BeiGene in July 2018, Josh Neiman has been serving as the Chief Commercial Officer for North America & Europe. His role includes overseeing the commercialization strategies and market expansion across these regions.
Early Career Experience
Josh Neiman co-founded Tao Biosciences and worked there as a Research Associate from 2000 to 2002. He later continued his research work at Plexxikon from 2002 to 2004. He also gained substantial industry insights through various roles at Genentech, including Group Product Manager and Clinical Oncology Specialist.